Ga offline met de app Player FM !
#164 - Amanda Smith, M.D.: Diagnosing, preventing, and treating Alzheimer’s disease, and what we can all learn from patients with dementia
Manage episode 294325406 series 2352826
We discuss:
- How Amanda developed a passion for geriatric psychiatry [3:15];
- Defining and diagnosing dementia and Alzheimer’s disease [13:30];
- Medical tests for dementia and their relationship to clinical symptoms [22:45];
- The pathology of dementia, and the role of the tau and beta-amyloid protein in Alzheimer’s disease [33:15];
- The significance of ApoE genotype, and differentiating Alzheimer’s disease from Lewy body dementia [43:15];
- The evolution of Alzheimer’s disease prevention, care, and medications over the last 20 years [52:45];
- Psychiatric support for dementia patients (and caregivers) with depression and anxiety [1:02:45];
- Drug pipeline, clinical trials, and major challenges to overcome [1:13:45];
- Redefining Alzheimer’s disease and designing effective trials [1:23:00];
- The promise of monoclonal antibody treatments for Alzheimer’s disease [1:34:15];
- How we should measure outcomes in dementia trials and define “healthy aging” [1:42:30];
- How understanding dementia can reshape our life philosophy [1:53:45]; and
- More.
Learn more: https://peterattiamd.com/ Show notes page for this episode: https://peterattiamd.com/AmandaSmith Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on Facebook | Twitter | Instagram.
347 afleveringen
Manage episode 294325406 series 2352826
We discuss:
- How Amanda developed a passion for geriatric psychiatry [3:15];
- Defining and diagnosing dementia and Alzheimer’s disease [13:30];
- Medical tests for dementia and their relationship to clinical symptoms [22:45];
- The pathology of dementia, and the role of the tau and beta-amyloid protein in Alzheimer’s disease [33:15];
- The significance of ApoE genotype, and differentiating Alzheimer’s disease from Lewy body dementia [43:15];
- The evolution of Alzheimer’s disease prevention, care, and medications over the last 20 years [52:45];
- Psychiatric support for dementia patients (and caregivers) with depression and anxiety [1:02:45];
- Drug pipeline, clinical trials, and major challenges to overcome [1:13:45];
- Redefining Alzheimer’s disease and designing effective trials [1:23:00];
- The promise of monoclonal antibody treatments for Alzheimer’s disease [1:34:15];
- How we should measure outcomes in dementia trials and define “healthy aging” [1:42:30];
- How understanding dementia can reshape our life philosophy [1:53:45]; and
- More.
Learn more: https://peterattiamd.com/ Show notes page for this episode: https://peterattiamd.com/AmandaSmith Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on Facebook | Twitter | Instagram.
347 afleveringen
Alle afleveringen
×Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.